Anika Therapeutics to Host Analyst and Investor Day on September 18, 2019
Anika’s leadership team will provide updates on its transformation into a global commercial company and highlights from the Company’s 5-year strategic plan. Additionally, they will be joined by the following world leading clinicians to provide insights about current and potential new treatments in orthopedic and regenerative medicine.
Mohit Bhandari, MD, Ph.D., FRCSC, Professor, Orthopaedic Surgery at McMaster University Timothy Deakon, MD, Orthopaedic Surgeon, Director of the Oakville Sports Injury Clinic
- Kevin Plancher, MD, FAAD, Orthopaedic Surgeon, Plancher Orthopaedics & Sports Medicine
Konrad Slynarski, MD, Ph.D., Orthopaedic Surgeon, President of the
Polish Arthroscopy Society John Tierney, DO, Orthopaedic Surgeon, President of the Greater Boston Orthopaedic Center
A live audio webcast of the event may be accessed via the “Investor Relations” section of Anika’s website at www.anikatherapeutics.com. An audio archive of the webcast also will be available on the website.
For Investor Inquiries:
Anika Therapeutics, Inc.
Sylvia Cheung, 781-457-9000
Chief Financial Officer
For Media Inquiries:
Sonal Vasudev, 917-523-1418